Penumbra (PEN) Gains from Investment Securities (2015 - 2026)
Penumbra (PEN) reported Gains from Investment Securities of $1.3 million for Q1 2026, up 110.44% year-over-year from $613000.0 in Q1 2025, and down 80.31% quarter-over-quarter from $6.6 million in Q4 2025.
Penumbra (PEN) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Penumbra (PEN) has 12 years of Gains from Investment Securities data on file, last reported at $1.3 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $1.3 million, up 110.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 million (up 1453.2% YoY), and the FY2025 annual result was $9.5 million, up 1950.0% from the prior year.
- Gains from Investment Securities fell to $1.3 million in Q1 2026 per PEN's latest filing, from $6.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $8.0 million in Q4 2022 and troughed at -$1.5 million in Q4 2024.
- A 5-year average of $1.3 million and a median of $613000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 5300.0% in 2023, then plunged 259.68% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $8.0 million in 2022, then sank by 88.5% to $925000.0 in 2023, then sank by 259.68% to -$1.5 million in 2024, then surged by 543.67% to $6.6 million in 2025, then tumbled by 80.31% to $1.3 million in 2026.
- Business Quant data shows PEN's Gains from Investment Securities at $1.3 million in Q1 2026, $6.6 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 6.55 Mn |
| Dec 31, 2025 | 6.55 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 777,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -396,000.00 |
| Jun 30, 2024 | -396,000.00 |
| Mar 31, 2024 | 421,000.00 |
| Mar 31, 2024 | 421,000.00 |
| Dec 31, 2023 | 925,000.00 |
| Dec 31, 2023 | 925,000.00 |